Literature DB >> 3767949

Binding of apoA-IV-phospholipid complexes to plasma membranes of rat liver.

G Ghiselli, W L Crump, A M Gotto.   

Abstract

Rat apoA-IV complexes with dimyristoyl phosphatidylcholine (apoA-IV-DMPC) have been prepared and their ability to bind to purified rat liver plasma membranes investigated. Binding equilibrium at 37 degrees C was reached in 30 minutes. Saturation binding experiments and subsequent analysis of the results with Scatchard plots gave results consistent with the presence of a single saturable binding site. DMPC or POPC unilamellar vesicles could not compete with apoA-IV-DMPC for binding; apoA-I-DMPC competed only partially. ApoE-poor HDL effectively competed with apoA-IV-DMPC. The fact that binding could be greatly reduced (greater than 70%) by preincubating the membrane with pronase (18 micrograms/ml), supports the conclusion that a membrane protein is involved in binding. Based on these results, we speculate that the rapid catabolism of apoA-IV in plasma may be mediated by a specific uptake mechanism in the liver. The implications of these results support the hypothesis that apoA-IV is involved in reverse cholesterol transport.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3767949     DOI: 10.1016/s0006-291x(86)80088-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Study of the sequence tagged site (STS) in the beginning of human apo A4 gene region.

Authors:  P de Temmerman; S Visvikis; E Boerwinkle; G Siest
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

2.  Effect of peripheral administration of cholecystokinin on food intake in apolipoprotein AIV knockout mice.

Authors:  Go Yoshimichi; Chunmin C Lo; Kellie L K Tamashiro; Liyun Ma; Dana M Lee; Denovan P Begg; Min Liu; Randall R Sakai; Stephen C Woods; Hironobu Yoshimatsu; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-29       Impact factor: 4.052

3.  Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients.

Authors:  E Pardina; M D López-Tejero; R Llamas; R Catalán; R Galard; H Allende; V Vargas; A Lecube; J M Fort; J A Baena-Fustegueras; J Peinado-Onsurbe
Journal:  Obes Surg       Date:  2009-01-27       Impact factor: 4.129

4.  Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats.

Authors:  K Fujimoto; K Fukagawa; T Sakata; P Tso
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population.

Authors:  A von Eckardstein; H Funke; M Schulte; M Erren; H Schulte; G Assmann
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

6.  A three-dimensional homology model of lipid-free apolipoprotein A-IV using cross-linking and mass spectrometry.

Authors:  Matthew R Tubb; R A Gangani D Silva; Jianwen Fang; Patrick Tso; W Sean Davidson
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

7.  Effect of intraperitoneal and intravenous administration of cholecystokinin-8 and apolipoprotein AIV on intestinal lymphatic CCK-8 and apo AIV concentration.

Authors:  Chun-Min Lo; Min Xu; Qing Yang; Shuqin Zheng; Katherine M Carey; Matthew R Tubb; W Sean Davidson; Min Liu; Stephen C Woods; Patrick Tso
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-11-19       Impact factor: 3.619

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.